Hyperbaric oxygen treatment of central retinal vein occlusion with cilioretinal artery occlusion secondary to hormonal treatment: Case report and review

This report describes a case of central retinal vein occlusion (CRVO) and cilioretinal artery occlusion (CLRAO) after hormonal treatment for induction of ovulation that was successfully treated with hyperbaric oxygen. A 48 year-old woman was admitted to our department for sudden blurred vision in he...

Full description

Saved in:
Bibliographic Details
Published inDiving and hyperbaric medicine Vol. 50; no. 4; pp. 431 - 436
Main Authors Khallouli, Asma, Khelifi, Khaled, Saidane, Rahma, Choura, Racem, Maalej, Afef, Sassi, Raja Ben
Format Journal Article
LanguageEnglish
Published Australia The Journal of the South Pacific Underwater Medicine Society and the European Underwater and Baromedical Society 20.12.2020
Subjects
Case Report
Ciliary Arteries
Female
Fluorescein Angiography
Humans
Hyperbaric Oxygenation
Middle Aged
Oxygen
Retinal Artery Occlusion - therapy
Retinal Vein Occlusion - complications
Retinal Vein Occlusion - therapy
Retinal vein occlusion
Female
Fertility agents
Cilioretinal artery occlusion
Online AccessGet full text

Cover

More Information
Summary:This report describes a case of central retinal vein occlusion (CRVO) and cilioretinal artery occlusion (CLRAO) after hormonal treatment for induction of ovulation that was successfully treated with hyperbaric oxygen. A 48 year-old woman was admitted to our department for sudden blurred vision in her left eye. The patient had a history of 3-months hormonal treatment for induction of ovulation. The best corrected visual acuity was 7/10 (20/32) in the left eye and 10/10 (20/20) in the right eye. Fundus examination of the left eye revealed flame-shaped haemorrhages, whitening of the retina along the distribution of cilioretinal artery and tortuous retinal veins. Fluorescein angiography confirmed the combination of a non-ischaemic CRVO with CLRAO. The patient was treated with a 2 h session of hyperbaric oxygen at 253 kPa (2.5 atmospheres absolute) once daily for a total of 30 sessions. Best corrected visual acuity improved to 10/10 (20/20) in the left eye. CRVO and CLRAO are both occlusive disorders. HBOT is a safe low-cost treatment modality that can be beneficial in some ocular pathologies. It can maintain oxygenation of the retina through the choroidal blood supply, decrease oedema and preserve compromised tissue adjacent to the ischaemic area.
ISSN:1833-3516
2209-1491
2209-1491
DOI:10.28920/dhm50.4.431-436